RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SELVAGGI G
Collezione AOU San Luigi di Orbassano

Items : 16

Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2010 Mar 20;28(9):1534-9. doi: 10.1200/JCO.2009.25.9275. Epub 2010 Feb 22.

2010
AOU San Luigi di Orbassano

Righi L; Papotti MG; Ceppi P; Billè A; Bacillo E; Molinaro L; Ruffini E; Scagliotti GV; Selvaggi G;

Histologic subtype in NSCLC: does it matter? in Oncology (Williston Park, N.Y.) / Oncology (Williston Park). 2009 Nov 30;23(13):1133-40.

2009
AOU San Luigi di Orbassano

Selvaggi G; Scagliotti GV;

Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2008 Jun;3(6):583-9. doi: 10.1097/JTO.0b013e3181734f24.

2008
AOU San Luigi di Orbassano

Ceppi P; Longo M; Volante M; Novello S; Cappia S; Bacillo E; Selvaggi G; Saviozzi S; Calogero R; Papotti M; Scagliotti GV;

New data integrating multitargeted antifolates into treatment of first-line and relapsed non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2008;9 Suppl 3:S122-8. doi: 10.3816/CLC.2008.s.018.

2008
AOU San Luigi di Orbassano

Scagliotti GV; Selvaggi G;

Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2007 May;18(5):903-8. doi: 10.1093/annonc/mdm061. Epub 2007 Mar 9.

2007
AOU San Luigi di Orbassano

Novello S; Bruzzi P; Barone C; Buosi R; Masotti A; Michetti G; Fioretti M; Barbera S; Spatafora M; Garetto L; Mazzanti P; Dongiovanni V; Selvaggi G; Crinò L; Scagliotti GV;

Emerging drugs for mesothelioma. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2007 Mar;12(1):127-37. doi: 10.1517/14728214.12.1.127.

2007
AOU San Luigi di Orbassano

Scagliotti GV; Selvaggi G;

Perspectives in adjuvant chemotherapy in NSCLC. in Expert review of respiratory medicine / Expert Rev Respir Med. 2007 Aug;1(1):99-110. doi: 10.1586/17476348.1.1.99.

2007
AOU San Luigi di Orbassano

Selvaggi G; Scagliotti GV;

Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer. in Clinical lung cancer / Clin Lung Cancer. 2006 May;7(6):395-400. doi: 10.3816/CLC.2006.n.023.

2006
AOU San Luigi di Orbassano

Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV;

Antimetabolites and cancer: emerging data with a focus on antifolates. in Expert opinion on therapeutic patents / Expert Opin Ther Pat. 2006 Feb;16(2):189-200. doi: 10.1517/13543776.16.2.189.

2006
AOU San Luigi di Orbassano

Scagliotti GV; Selvaggi G;

Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2005 Oct;16(10):1662-6. doi: 10.1093/annonc/mdi314. Epub 2005 Jul 8.

2005
AOU San Luigi di Orbassano

Novello S; Fava C; Borasio P; Dogliotti L; Cortese G; Crida B; Selvaggi G; Lausi P; Brizzi MP; Sperone P; Cardinale L; Ferraris F; Perotto F; Priola A; Scagliotti GV;

Pemetrexed combined with oxaliplatin or carboplatin as first-line treatment in advanced non-small cell lung cancer: a multicenter, randomized, phase II trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):690-6.

2005
AOU San Luigi di Orbassano

Scagliotti GV; Kortsik C; Dark GG; Price A; Manegold C; Rosell R; O'Brien M; Peterson PM; Castellano D; Selvaggi G; Novello S; Blatter J; Kayitalire L; Crino L; Paz-Ares L;

Management of bone metastases in cancer: a review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2005 Dec;56(3):365-78. doi: 10.1016/j.critrevonc.2005.03.011. Epub 2005 Jun

2005
AOU San Luigi di Orbassano

Selvaggi G; Scagliotti GV;

HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival. in Cancer / Cancer. 2002 May 15;94(10):2669-74. doi: 10.1002/cncr.10531.

2002
AOU San Luigi di Orbassano

Selvaggi G; Scagliotti GV; Torri V; Novello S; Leonardo E; Cappia S; Mossetti C; Ardissone F; Lausi P; Borasio P;

Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2001 Nov;34(2):261-9. doi: 10.1016/s0169-5002(01)00238-0.

2001
AOU San Luigi di Orbassano

Novello S; Galli L; Antonuzzo A; Crinó L; Pozzi E; Selvaggi G; Ricci S; Marrocolo F; Darwish S; Sorbolini S; Tonato M; Scagliotti GV;

Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 1999 Jul;25(1):39-46. doi: 10.1016/s0169-5002(99)00048-3.

1999
AOU San Luigi di Orbassano

Scagliotti GV; Crinó L; Pozzi E; Corgna E; Selvaggi G; Novello S; Salsano G; Gentile A; Palladino M; Marracolo F; Tonato M;

Multidrug resistance in non-small-cell lung cancer. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 1999;10 Suppl 5:S83-6. doi: 10.1093/annonc/10.suppl_5.s83.

1999
AOU San Luigi di Orbassano

Scagliotti GV; Novello S; Selvaggi G;